Kolexia
Héquet Delphine
Gynécologie
Clinique Oudinot
Paris, France
139 Activités
891 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Récidive tumorale locale Infections à papillomavirus Tumeurs du col de l'utérus Tumeurs de l'ovaire COVID-19 Placenta accreta Hémorragie de la délivrance Invasion tumorale

Industries

Amgen
3 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
Roche
2 collaboration(s)
Dernière en 2021
EXACT SCIENCES FRANCE SAS
2 collaboration(s)
Dernière en 2023

Dernières activités

Regional spread of an atypical ESBL-producing ST131H89 clone among different human and environmental reservoirs in Western Switzerland.
Antimicrobial agents and chemotherapy   03 janvier 2024
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.
Cancer medicine   06 juillet 2023
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.
Frontiers in oncology   23 juin 2023
Prevalence of sexual dysfunction after breast cancer compared to controls, a study from CONSTANCES cohort.
Journal of cancer survivorship : research and practice   06 juin 2023
112P Correlation between HER2-negative status and risk of recurrence according to PAM50 score
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort.
Swiss medical weekly   31 mars 2023
CHACRY-1501: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Essai Clinique (Centre Oscar-Lambret)   13 février 2023
Sexuality after breast cancer, how to provide a global and contemporary approach.
Bulletin du cancer   03 novembre 2022
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
13th European Breast Cancer Conference (EBCC-13)   01 novembre 2022
Impact of the COVID-19 pandemic on breast cancer management: Experience of a French Comprehensive Cancer Center.
Bulletin du cancer   27 septembre 2022